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The platelet-derived growth factors (PDGFs) are a family of potent mitogens and chemoattractants for cells of mesenchymal origin, such as fibroblasts and smooth muscle cells, and are thought to play a key reparative role during wound healing or post-angioplasty restenosis (4) . PDGFs span four distinct ligand chains (A, B, C, D) and two cell surface receptor subunits (␣ and ␤). Ligand binding results in receptor dimerization and autophosphorylation, and the activation of signal transduction pathways (2, 18) . Unlike PDGF-receptor (R)-␤, PDGF-R-␣ binds all forms of PDGFs except for PDGF-DD (38) . PDGF-R-␣ is ubiquitously expressed and mediates cell proliferation and migration (40) . PDGF-R-␣ is induced by dermal injury (8) , and impaired wound healing correlates with lower PDGF-R-␣ expression (8) . However, little is known about the control of PDGF-R-␣ levels after induction. The transcriptional mechanisms regulating PDGF-R-␣ expression are poorly understood. The PDGF-R-␣ gene lacks a TATA box but contains GATA motifs and a CCAAT box (21) . It also contains putative transcriptional binding sites for members of the activator protein 1 (AP-1) and Oct families (21) . CCAAT-enhancer-binding proteins (C/EBP)-␤ and -␦ have been shown to bind regions within the PDGF-R-␣ promoter (21) . Previous studies by our group have demonstrated that Sp1 and Ets-1 under stimulation by peroxide and FGF-2 increase PDGF-R-␣ transcription (10, 11) .
TNF-␣ has long been implicated in the process of wound healing. For example, inhibition of TNF-␣ improves healing of excisional wounds in diabetic mice and increases fibroblast density (34) . TNF-␣ has also been shown to impair the wound healing process in scars (24) . TNF-␣ suppression of ␣-smooth muscle actin expression in fibroblasts has been implicated as a basis for abnormal wound healing (15) . Mechanisms regulating the effects of TNF-␣ in the cellular response to injury require further investigation beyond already known mechanisms (1, 17, 20) . This would provide insights into the complexity of wound healing and may suggest new therapeutic approaches. Here we show that the transcriptional repression of PDGF-R-␣ after injury involves paracrine activation by TNF-␣, the formation of a complex between c-Fos and Yin Yang 1 (YY1), and negative regulatory activity by histone deacetylase (HDAC).
MATERIALS AND METHODS
Cell culture and reagents. Mouse embryonic fibroblasts NIH-3T3 cells were purchased from American Type Culture Collection (ATCC) and cultured in Dulbecco's modified Eagle's medium (DMEM) pH 7.4, supplemented with fetal bovine serum (FBS) and antibiotics at 37°C and 5% CO 2 as described (23) . DU145 and PC3 prostate cancer cells were obtained as a gift of Dr. Paul De Souza (St George Hospital, Sydney, Australia) and cultured in RPMI medium supplemented with FBS, 10 U/ml penicillin and 10 g/ml streptomycin at 37°C and 5% CO 2. HeLa cervical cancer cells were purchased from ATCC and cultured in RPMI medium supplemented with FBS, 10 U/ml penicillin, and 10 g/ml streptomycin at 37°C and 5% CO 2. The cells were passaged every 3-4 days in 75-cm 2 flasks. Cells were incubated for 24 h in serum-free media to achieve growth-quiescence before exposure to agonists or inhibitors or subjected to injury. Recombinant human TNF-␣ was purchased from Sigma. Suberoylanilide hydroxamic acid (SAHA) was purchased from Sigma. Rabbit polyclonal antibodies to c-Fos, YY1, PDGF-R-␣, and HDAC-1 were purchased from Santa Cruz Biotechnology. Mouse monoclonal antibodies to ␤-actin were obtained from Sigma. Protein A/G agarose was obtained from Am-ersham. YY1, c-Fos, or HDAC-1 small interfering RNA (siRNA), and control or scrambled siRNA, were obtained from Santa Cruz and Qiagen.
Mechanical cell injury. Scratch injury was performed with fibroblasts in 100-cm 2 dishes as previously described (22) . Growth-quiescent cells were left for varying times after injury, and samples were collected for mRNA, protein and medium for enzyme-linked immunosorbent assay (ELISA). Where indicated to the culture supernatant was added neutralizing antibodies to TNF-␣ or IgG (25 g/ml final concentration) for 1 h before scraping.
ELISA. TNF-␣ levels were determined by ELISA purchased from Bio-Scientific, according to the manufacturer's instructions. Results were analyzed using a SpectraMax-Plus plate reader (Molecular Devices) and the SoftMax Pro program. TNF-␣ levels were derived from a standard curve, plotted using standards provided by the manufacturer.
Plasmid constructs and site-directed mutagenesis. pLuc-␣2 containing the promoter region of PDGF-R-␣ was a generous gift from Dr. Yutake Kitami (Ehime University School of Medicine, Ehime, Japan). c-Fos expression plasmid was generated by insertion of c-Fos cDNA into the HindIII site of pcDNA3. Mutations were introduced using the QuikChange II XL-Site directed Mutagenesis Kit (Stratagene). pcDNA3-YY1 was generated by inserting a 1.5 kb fragment of YY1 into EcoRI site of pcDNA3.
Transient transfection analysis. For reporter gene analysis, fibroblasts were transfected with 1 g pLuc-␣2 together with 1 g pRL-TK (Promega) to correct for transfection efficiency. For YY1 and c-Fos studies, 10 g of pcDNA3-YY1 or pcDNA3-c-Fos was transfected with the reporter plasmids. Transient transfection was performed using FuGENE6 (Roche). After incubation at 22°C for 15 min, the DNA/FuGENE6 mixture was added to cells in 10 ml complete medium. At 12 h after transfection, cell lysates were prepared for assessment of luciferase activity using the Dual luciferase assay reporter system (DLR) (Promega) and an automated luminometer (Veritas).
Conventional RT-PCR. Cells were washed twice with ice-cold PBS, pH 7.4, and harvested using RNeasy minispin column kit (Qiagen) in accordance with the manufacturer's instructions. cDNA synthesis from total RNA was performed using Superscript II RT (Invitrogen) in accordance with the manufacturer's instructions. Thermal cycling conditions were as follows: for PDGF-R-␣: 94°C for 10 s, 62°C for 30 s, 72°C for 1.5 min for 23-27 cycles; for GAPDH: 94°C for 30 s, 60°C for 30 s, 68°C for 30 s for 21-23 cycles. PDGF-R-␣ primers were as follows: forward 5=-AGA TAG CTT CAT GAG CCG AC-3= and reverse 5=-GGA ACA GGG TCA ATG TCT GG-3=. GAPDH primers were as follows: forward 5=-ACC ACA GTC CAT GCC ATC AC-3= and reverse 5=-TCC ACC ACC CTG TTG CTG TA-3=.
Quantitative real-time PCR. Quantitative PCR was carried out using the Rotor-Gene (Corbett Life Science). The reaction was set in a final volume of 10 l containing 1 l of cDNA, 5 l of 2 ϫ SYBR Green Master Mix (Applied Biosystems), 0.2 l of 10 M forward and reverse primer (Sigma) and 3.6 l of DNase-free water. Mouse PDGF-R-␣ primers were as follows: forward 5=-CAA ACC CTG AGA CCA CAA TG-3= and reverse 5=-TCC CCC AAC AGT AAC CCA AG-3=. ␤-Actin primers were as follows: forward 5=-AGC CAT GTA CGT AGC CAT CC-3= and reverse 5=-CTC TCA GCT GTG GTG GTG AA-3=. The PCR conditions were 95°C for 10 min, followed by 40 cycles at 95°C for 20 s and 60°C for 45 s, 72°C for 20 s.
Preparation of nuclear extracts. Fibroblasts were washed twice with ice-cold PBS, pH 7.4, and scraped with 10 ml of cold PBS. The cells were pelleted by centrifugation at 1,200 rpm for 15 min at 4°C. The cells were lysed with the addition of ice-cold hypotonic buffer A [10 mM HEPES, pH 7.9, 1.5 mM MgCl2, 10 mM KCl, 0.5 mM DTT, 200 mM sucrose, 0.5% Nonidet P-40, 0.5 mM phenylmethyl sulfonyl fluoride (PMSF), 1 g/ml leupeptin, and 1 g/ml aprotinin]. The suspension was centrifuged and nuclei were lysed in an ice-cold buffer C (20 mM HEPES, pH 7.9, 1.5 mM MgCl2, 420 mM NaCl, 0.2 mM EDTA, 1 mM DTT, 0.5 mM PMSF, 1 g/ml leupeptin, and 1 g/ml aprotinin). The nuclear fraction was combined with an equal volume of ice-cold buffer D (containing 20 mM HEPES, pH 7.9, 100 mM KCl, 0.2 mM EDTA, 20% glycerol, 1 mM DTT, 0.5 mM PMSF, 1 g/ml leupeptin, and 1 g/ml aprotinin). Nuclear extracts were stored at Ϫ80°C until use.
EMSA and supershift/antibody elimination analysis. Binding reactions were performed in 20 l of 10 mM Tris·HCl, 50 mM NaCl, 1 mM EDTA, 2 mM DTT, 5% glycerol, 0.5% Nonidet P-40, 1 mg/ml BSA, 32 P-labeled oligonucleotide probe (100,000 cpm), and added protein. The reaction was allowed to proceed for 30 min at 22°C. Bound complexes were separated from free probe by electrophoresis at 100 V with 6% nondenaturing polyacrylamide gels (14) . Gels were vacuum-dried at 80°C and subjected to autoradiography overnight at Ϫ20°C. Where indicated, supershift/antibody elimination analysis was performed by preincubating the extracts with antibodies for 30 min before the addition of the probe.
Chromatin immunoprecipitation analysis. Fibroblasts were incubated with 1% formaldehyde for 10 min, and quenched with glycine (0.1 M final concentration). The cells were washed twice with PBS, pH 7.4. Chromatin immunoprecipitation (ChIP) buffer, consisting of 150 mM NaCl, 5 mM EDTA, 1% Triton X-100, 0.5% NP-40, 50 mM Tris·HCl, pH 7.5, and 0.5 mM DTT, was added to the cells and scraped and collected. The cells were sonicated at 4 rounds of 15, 1 s each time. After spinning at 14,000 g for 10 min at 4°C, the supernatant was collected and evenly divided. Either no antibody was added or 5 g of rabbit polyclonal antibodies were added to the indicated targets (Santa Cruz Biotechnology). After incubation at 22°C for 1 h, sonication was performed at 4°C in a water bath for 15 min. The suspension was spun at 14,000 g for 10 min at 4°C and the supernatant was collected. Washed protein A-and G-Sepharose beads were added to the supernatant and rotated at 4°C for 1 h. The suspension was centrifuged and the supernatant was removed with 30 1/2-gauge syringes. The beads were washed with ChIP buffer five times. Chelex was added and the suspension was boiled for 10 min. The suspension was treated with proteinase K at 55°C for 30 min while spinning. The suspension was boiled again for 10 min. The suspension was centrifuged and the supernatant was collected. Phenol-chloroform extraction and ethanol precipitation were conducted overnight at Ϫ20°C. The fragment of PDGF-R-␣ promoter was amplified by PCR. PDGF-R-␣ primers used were as follows: forward 5=-CAA AAC AAT AGC ACC CCC AC-3= and reverse 5=-CCG TCC TCC AAA AAC TAA TCA-3=. Thermal cycling conditions were as follows: 94°C for 30 s, 58°C for 30 s, 72°C for 45 s for 45 cycles.
Coimmunoprecipitation analysis. Nuclear extracts were precleared with prewashed (buffer CϩD) protein A-and G-Sepharose beads overnight at 4°C while rotating. Primary antibodies were added to the supernatant and incubated at 4°C overnight with spinning. Prewashed protein A-and G-Sepharose beads were added again and incubated with the suspension overnight with spinning at 4°C. The suspension was washed with buffer CϩD three times. The supernatant was resuspended in 4ϫ SDS sample buffer and analyzed by Western blotting with the antibodies indicated. We performed coimmunoprecipitation analysis using TNF-␣ as a model agonist rather than scratch injury as the latter is a comparatively weaker stimulus.
Western blotting. Immunoblotting was performed as previously described (29) . Briefly, cells were washed twice with ice-cold PBS before lysis on ice in 1ϫ RIPA buffer (50 mM Tris·HCl, pH 7.5, 150 mM NaCl, 1% Triton X-100, 1% deoxycholate, 0.1% SDS) containing protease inhibitors (2 mM PMSF, 5 mM EDTA, 10 g/ml leupeptin, and 1% aprotinin) or nuclear extracts. Cell lysates were collected after centrifugation at 14,000 g for 20 min at 4°C, and protein concentration was determined by BCA protein assay (Pierce). Lysates were prepared in SDS sample buffer (50 mM Tris, pH 6.8, 10% glycerol, 2% SDS, 0.01% bromophenol blue, and 30 mM DTT) and boiled for 5 min with 0.5 M iodoacetamide then loaded onto 6 or 10% SDS-polyacrylamide gel. Gels were blotted onto Immobilon-P membranes for chemiluminescence detection or Immobilon-Fl for Odyssey fluorescence detection (Millipore). Membranes were blocked with 5% skim milk (37) or blocking solution (Rockland) overnight at 4°C. Chemiluminescence detection (NEN Life Sciences Products) was conducted according to the manufacturer's instructions, and fluorescence was detected by Licor Odyssey system.
RESULTS
Reduced PDGF-R-␣ expression after cell injury is due to the release and paracrine activity of TNF-␣. PDGF-R-␣ null mice show severe dermal defects and reduced healing ability (8) . This indicates the importance of this receptor in wound repair. We subjected fibroblasts to in vitro mechanical injury and found that PDGF-R-␣ expression decreased at the level of both mRNA and protein after 48 h (Fig. 1, A and B, columns 1 and   2 ). Since wound healing is accelerated in TNF receptor p55-deficient mice (26), we hypothesized that TNF-␣ may play a role in the altered expression of PDGF-R-␣. Accordingly, we incubated fibroblasts with isotype-matched IgG or neutralizing TNF-␣ antibodies for 1 h before injury. Reduced PDGF-R-␣ mRNA expression after injury was prevented by preincubation with TNF-␣ antibodies, but not by IgG (Fig. 1B) . These findings suggest that injury caused the release of TNF-␣ into the culture medium. To verify this, we measured TNF-␣ levels in the supernatant by ELISA and found increased levels of TNF-␣ between 24 and 48 h postinjury (Fig. 1C) . In support of these findings, recombinant TNF-␣ reduced PDGF-R-␣ expression at the level of protein (Fig. 1D) and mRNA (Fig. 1E) . TNF-␣ inhibition of PDGF-R-␣ expression was both time (Fig.  1E ) and dose dependent (Fig. 1F) . Fig. 1 . Reduced PDGF-receptor (R)-␣ expression after in vitro injury is due to the release of TNF-␣. A: growth quiescent fibroblasts were injured in vitro by scraping and left for 48 h before Western blotting for PDGF-R-␣ or ␤-actin. B: neutralizing antibodies to TNF-␣, or isotype-matched IgG was added to the culture medium (25 g/ml final concentration) and allowed to incubate for 1 h before scraping. Quantitative realtime PCR was performed after 48 h. TNFNA denotes neutralizing antibodies to TNF-␣. C: TNF-␣ levels were determined in the culture supernatant by ELISA various times after injury. D: TNF-␣ (10 ng/ml) was incubated with the fibroblasts for 4 h before assessment of PDGF-R-␣ or ␤-actin immunoreactivity in the total cell lysates by Western blotting. E: TNF-␣ (10 ng/ml) was incubated with the fibroblasts for various times before harvest of total RNA and determination of PDGF-R-␣ mRNA levels by quantitative real-time PCR. F: various concentrations of TNF-␣ were incubated with the fibroblasts for 4 h before harvest of total RNA and determination of PDGF-R-␣ mRNA levels by quantitative real-time PCR. *P Ͻ 0.05.
c-Fos, induced by TNF-␣, binds PDGF-R-␣ promoter fragment and negatively regulates PDGF-R-␣ transcription. TESS analysis (Transcription Element
Search System, www.cbil.upenn.edu) of the PDGF-R-␣ promoter revealed the existence of a putative binding element for the transcription factor AP-1 at Ϫ116 AGAGTCA Ϫ110 (Fig. 2) . Overexpression of the immediate-early gene product and prototypic AP-1 family member c-Fos (in pcDNA3) in a transient cotransfection setting with a Firefly luciferase construct driven by 1,000 bp of the human PDGF-R-␣ promoter resulted in reduced reporter activity as compared with pcDNA3 alone (Fig. 3A) . TNF-␣ increased c-Fos mRNA (Fig. 3B, left) and c-Fos protein (Fig. 3B, right) expression after 1 h.
We performed EMSA with double-stranded oligonucleotide spanning the Ϫ116 AGAGTCA Ϫ110 element ( 32 P-labeled Oligo PDGF-R-␣ Ϫ128/Ϫ98 ) and nuclear extracts of fibroblasts exposed to TNF-␣. This resulted in the appearance of an inducible nucleoprotein complex, which was eliminated by prior incubation with antibodies to c-Fos (Fig. 3C, left) , whereas antibodies to an irrelevant target, USF-1, had no effect (Fig.  3C, left) ) in EMSA, formation of this TNF-␣-inducible nucleoprotein complex was abolished (Fig. 3C,  right) . Introduction of this mutation into the PDGF-R-␣ promoter-reporter construct (pLuc-m␣2 Ϫ116 ATCGGAC Ϫ110 ) abolished the ability of TNF-␣ to repress the PDGF-R-␣ promoter (Fig. 3D) .
c-Fos and YY1 siRNA inhibit TNF-␣ suppression of PDGF-R-␣ expression. To further confirm the negative regulatory role of c-Fos in PDGF-R-␣ expression, we transfected fibroblasts with siRNA targeting murine c-Fos or negative control siRNA (Qiagen) and exposed the cells to TNF-␣. In this setting, TNF-␣ inhibition of PDGF-R-␣ was alleviated in cells transfected with c-Fos siRNA but not control siRNA (Fig. 4A) .
In this experiment we also used murine YY1 siRNA as a negative control. However, to our surprise we found that YY1 siRNA, like c-Fos siRNA, reduced TNF-␣ repression of PDGF-R-␣ expression (Fig. 4A) . This led us to explore whether this zinc finger transcription factor regulates PDGF-R-␣ promoter activity. TESS analysis suggested the existence of a putative YY1 binding site in the PDGF-R-␣ promoter at Ϫ468 CCATAT Ϫ463 (Fig. 2) . YY1 negatively regulates PDGF-R-␣ transcription. EMSA was performed with 32 P-Oligo PDGF-R-␣ Ϫ484/Ϫ464 and extracts of cells treated with TNF-␣. A basal complex formed (Fig. 4B, left) , which increased in intensity after treatment with TNF-␣ (Fig. 4B, left) . This complex was reduced with antibodies to YY1 (Fig. 4B, left) . The intensity of this complex was reduced to basal levels by antibodies to c-Fos (Fig. 4B, left) , suggesting that, under these nondenaturing conditions, one or both factors are bound directly or indirectly to the probe. In contrast, antibodies to ATF-4 had no effect (Fig. 4B, left) .
Mutation of the
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Ϫ463 element to produce 32 POligo mPDGF-R-␣ Ϫ484/Ϫ464 abolished complex formation (Fig. 4B, right) . Cotransfection of pLuc-␣2 with a YY1 expression vector repressed PDGF-R-␣ promoter activity, whereas expression driven by pLuc-m␣2 Ϫ468 TTGTAC Ϫ463 was not inhibited by YY1 (Fig. 4C) .
TNF-␣ stimulates formation of a complex containing c-Fos and YY1.
Coimmunoprecipitation analysis was performed on extracts of cells treated with TNF-␣ (10 ng/ml) for 1 h. TNF-␣ stimulated c-Fos expression, without affecting levels of YY1 or ␤-actin (Fig. 5) . Pulling down with c-Fos antibodies and then immunoblotting with YY1 antibodies revealed that TNF-␣ induced the formation of a complex containing c-Fos and YY1 (Fig. 5) . HDAC-1 does not form part of a TNF-␣-inducible complex, even though it is expressed in the absence and presence of TNF-␣ (Fig. 5) .
Enrichment of c-Fos, YY1, and HDAC-1 at the PDGF-R-␣ promoter.
We next determined whether c-Fos and YY1 associate with the authentic PDGF-R-␣ promoter. ChIP analysis revealed the enrichment of c-Fos and YY1 at the PDGF-R-␣ promoter within 2 h of exposure to TNF-␣ (Fig. 6) . TNF-␣ also increased levels of HDAC-1 at the promoter after this time (Fig. 6) .
HDAC activity regulates TNF-␣ repression of PDGF-R-␣ expression.
The increased occupancy of the PDGF-R-␣ promoter by HDAC-1 suggested that HDACs may play a functional role in TNF-␣ repression of PDGF-R-␣. HDACs play a critical role in epigenetic gene silencing, effecting compact chromatin structure by removing acetyl groups from lysine residues in the tails of core histones. We explored the role of HDAC as a potential cofactor in the effect of TNF-␣ on PDGF-R-␣ by using the HDAC inhibitor suberoylanilide hydroxamic acid (SAHA). SAHA (1 ng/ml) reversed TNF-␣ repression of PDGF-R-␣ mRNA expression (Fig. 7A) . In contrast, SAHA alone had no effect (Fig. 7A) . This was supported by further experiments silencing HDAC-1. TNF-␣ inhibition of PDGF-R-␣ expression was blocked by HDAC-1 siRNA, whereas scrambled siRNA had no effect (Fig. 7B) . These data indicate the involvement of HDAC-1 for TNF-␣ suppression of PDGF-R-␣.
DISCUSSION
Wound healing is a complex pathophysiologic response to injury involving a number of distinct phases such as initiation, progression, and resolution. This reparative response includes the induction of acute inflammation by the initial injury, followed by cell proliferation, migration, and the production and elaboration of the extracellular matrix. These cellular changes are underpinned by signaling and transcriptional networks that are in turn influenced by the local microenvironment. Fibroblasts are among the key cell types involved in this process. These cells produce cytokines and matrix components such as fibronectin and collagen, which serve as platforms for proliferation and migration. While it is clear that cytokines are secreted early in response to injury, the molecular mechanisms that prevent the uncontrolled amplification of growth and migratory signals are poorly understood. PDGF-R-␣ is a major player in the process of wound healing (4) and mediates both Fig. 3 . c-Fos negatively regulates PDGF-R-␣ transcription. A: transient cotransfection analysis of pLuc-␣2 (and pRL-TK) with pcDNA3 or pcDNA3-c-Fos, and determination of luciferase activity after 24 h. Firefly luciferase activity was normalized to Renilla to correct for transfection efficiency. B: reverse-transcription PCR (left) and Western blotting (right) were performed on total RNA or extracts of fibroblasts exposed to TNF-␣ (10 ng/ml) for 1 h. C, left: EMSA with 32 P-Oligo PDGF-R-␣ Ϫ128/Ϫ98 and nuclear extracts of fibroblasts exposed to TNF-␣ (10 ng/ml) for 2 h. Supershift/antibody elimination analysis was performed by preincubating nuclear extracts with antibodies (Ab) to c-Fos or USF-1 (4 g). C, right: EMSA was performed as above but with . n.s., Nonspecific. D: fibroblasts transfected with pLuc-␣2 or pLuc-m␣2 Ϫ116 ATCGGAC Ϫ110 (and pRL-TK) were incubated with TNF-␣ (10 ng/ml) for 4 h, and luciferase was determined. Firefly luciferase activity was normalized to Renilla to correct for transfection efficiency. *P Ͻ 0.05. Ϫ484/Ϫ464 or 32 P-Oligo mPDGF-R-␣ Ϫ484/Ϫ464 and nuclear extracts of fibroblasts exposed to TNF-␣ (10 ng/ml) for 2 h. Supershift/antibody elimination analysis was performed by preincubating nuclear extracts with antibodies to YY1, c-Fos, or ATF-4 (4 g). C: fibroblasts transfected with pLuc-␣2 or pLuc-m␣2 Ϫ468 TTGTAC Ϫ463 (and pRL-TK) overnight and were incubated with TNF-␣ (10 ng/ml) for 4 h, and luciferase was determined. Firefly luciferase activity was normalized to Renilla to correct for transfection efficiency. D: transient cotransfection analysis of pLuc-␣2 (and pRL-TK) or pLucm␣2 Ϫ468 TTGTAC Ϫ463 with pcDNA3 or pcDNA-YY1, and determination of luciferase activity after 24 h. Firefly luciferase activity was normalized to Renilla to correct for transfection efficiency. *P Ͻ 0.05. cell proliferation and migration particularly of fibroblasts (2) . PDGF-R-␣-null mice display severe dermal mesenchymal hypoplasia and blistering (35) . Reduced wound healing in diabetic mice correlates with reduced expression of PDGF-A and PDGF-R-␣ (8). Insufficient PDGF-R-␣ levels can reduce fibroblast abundance and lead to impaired wound healing (39) . On the other hand, increased PDGF-R-␣ expression can lead to fibrosis and excessive scarring (13) . This critical balance determines the success of wound repair. In this study, we show that reduced PDGF-R-␣ expression after injury is due to the release and paracrine activity of TNF-␣. Using a variety of approaches we found that TNF-␣ can inhibit PDGF-R-␣ expression as a consequence of c-Fos and YY1-dependent repression of PDGF-R-␣ promoter activity. We have also demonstrated the negative regulatory influence of HDAC in this process.
TNF-␣ is a key component of the proinflammatory response after injury (16) . It stimulates the growth and migration of cells pivotal to the repair process, among them fibroblasts (5, 28).
However, negative regulation of this cell type is also important in the prevention of scarring and fibrosis, which may be caused by an overabundance of fibroblasts in the wound (13) . TNF-␣ is also a known antiproliferative factor for fibroblasts (25) . This ability to control fibroblast proliferation may represent a key mechanism controlling the healing response after cellular trauma. The antiproliferative effects of TNF-␣ on fibroblasts may be due to its ability to repress expression of a key growth factor receptor such as PDGF-R-␣. TNF-␣ suppression of PDGF-R-␣ expression to the best of our knowledge has not previously been demonstrated.
TNF-␣ regulates PDGF-R-␣ transcription through its effects on c-Fos and YY1. c-Fos is induced by TNF-␣ and negatively regulates PDGF-R-␣ transcription. A mutation in the PDGF-R-␣ promoter that prevents binding of c-Fos (
) perturbed the ability of TNF-␣ to repress the PDGF-R-␣ promoter. Inhibition of c-Fos or YY1 using the siRNA approach (9) blocked TNF-␣ suppression of PDGF-R-␣ expression. c-Fos is expressed during wound repair (27) and is a prototypic member of the AP-1 transcription factor family (19, 32, 33) which play an important role in wound healing (3) . YY1 is an injury-inducible GLI-Krüppel zinc finger protein (6, 30, 31) . This study is the first to identify functional c-Fos and YY1 binding elements in the PDGF-R-␣ promoter. To the best of our knowledge this is the first demonstration of an inducible complex containing c-Fos and YY1.
Histone acetylation and deacetylation play a dynamic role in the expression of genes. Acetylation of histone lysine residues causes the change in charge of the DNA causing a preference in the relaxing of the chromatin, which then allows for increased transcriptional activity (12) . Deacetylation on the other hand generally causes repression through the tightening of the chromatin structure and reduces binding of the transcriptional machinery to the promoter region (7). HDAC-1 does not form part of a TNF-␣-inducible c-Fos-YY1 complex, but is enriched at the PDGF-R-␣ promoter in cells exposed to TNF-␣. HDACs regulate TNF-␣ repression of PDGF-R-␣ from experiments using SAHA and HDAC-1 siRNA.
In summary, our findings provide important mechanistic insights into the reparative response to fibroblast injury, during which fibroblasts express and respond to cytokines and growth factors, including TNF-␣ and PDGF, in the local microenvironment. We have shown that fibroblast injury stimulates the release of endogenous TNF-␣, which in turn reduces the expression of PDGF-R-␣, the receptor subtype that binds PDGF-AA, PDGF-AB, and PDGF-BB. The repressive effect of endogenous TNF-␣ on PDGF-R-␣ expression is recapitulated by the exposure of uninjured fibroblasts to recombinant TNF-␣. PDGF-R-␣ suppression by TNF-␣ involves formation of a c-Fos-YY1 complex and negative regulation by HDAC. These data suggest that TNF-␣ suppression of PDGF-R-␣ in the setting of wound repair may help to prevent uncontrolled PDGF-dependent proliferation and scar formation during healing.
